Ethan V Abel

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2026
Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.

|Apr 10, 2026
Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance.

Vishnu Kumarasamy, Jianxin Wang, Edwin Yau

|Nov 19, 2025
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma.

Kennedy S Humphrey, Katherine J Crawford, Bharani Muppavarapu

|Feb 20, 2025
Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma.

Katherine J Crawford, Kennedy S Humphrey, Eduardo Cortes

|Jan 31, 2024
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer.

Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou

|Aug 04, 2018
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.

Ethan V Abel, Masashi Goto, Brian Magnuson

Pageof 1

Frequent Collaborators

5 joint publications

Erik S Knudsen

5 joint publications

Agnieszka K Witkiewicz

3 joint publications

Vishnu Kumarasamy

3 joint publications

Jianxin Wang